Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

AKAN Stock IPO: 7 Things to Know as Akanda Starts Trading Today

Here's what investors may want to know about medical cannabis company Akanda, as AKAN stock skyrockets on its first day of trading today.

Why Is Sonim Technologies (SONM) Stock Up Today?

Today, investors in Sonim Technologies and SONM stock are cheering a major announcement which investors expect could be a big deal.

IXHL Stock Alert: 7 Things to Know as Incannex Healthcare Skyrockets Too

Here's what investors intrigued by today's 100% rise in Incannex Healthcare and IXHL stock may want to know about this company.

7 Superstar Tech Stocks That May Outperform This Market Rout

These superstar tech stocks are among the best options for long-term growth investors looking to battle market volatility right now.

Why Is Luckin Coffee (LKNCY) Stock Down Today?

Here's what is driving Luckin Coffee and LKNCY stock dramatically lower today, as Chinese equities continue to get routed by the market.